v3.26.1
Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Net Income (Loss) Attributable to Common Stockholders and Transfers (to) from Noncontrolling Interests
The table below presents the effect on our equity from net (loss) income attributable to common stockholders and changes in our ownership interest in our Operating Partnership:
 Three Months Ended March 31,
(In thousands)20262025
Net (loss) income attributable to common stockholders$(2,498)$39,800 
Transfers from noncontrolling interests:
Exchange of OP Units with noncontrolling interests302 159 
Repurchases of OP Units from noncontrolling interests9 (9)
Net transfers from noncontrolling interests311 150 
Change from net (loss) income attributable to common stockholders and transfers from noncontrolling interests$(2,187)$39,950 
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents a reconciliation of our AOCI, which consists solely of adjustments related to derivatives designated as cash flow hedges:

Three Months Ended March 31,
(In thousands)20262025
Accumulated Other Comprehensive Income - Beginning balance$11,452 $54,917 
Consolidated derivatives:
Other comprehensive income (loss) before reclassifications11,717 (6,778)
Reclassification of gains from AOCI to Interest Expense(6,716)(22,050)
Unconsolidated Fund's derivatives (our share)(2):
Consolidation of unconsolidated Fund— (4,762)
Net current period OCI5,001 (33,590)
OCI attributable to noncontrolling interests(4,109)13,183 
OCI attributable to common stockholders892 (20,407)
Accumulated Other Comprehensive Income - Ending balance$12,344 $34,510 
___________________________________________________
(1)See Note 9 for the details of our derivatives and Note 12 for our derivative fair value disclosures.
(2)We did not have any unconsolidated entities during the three months ended March 31, 2026 and March 31, 2025. We consolidated Partnership X commencing on January 1, 2025. Our share of the Partnership X's OCI on January 1, 2025 was reclassified to the gain from consolidation we recorded. See Note 3 regarding the consolidation of Partnership X.
Schedule of Stock-based Compensation Expense The table below presents our stock-based compensation expense:
Three Months Ended March 31,
(In thousands)20262025
Stock-based compensation expense, net$2,720 $2,730 
Capitalized stock-based compensation$645 $655